Search Browse Earnings

Rezolute, Inc. — SlamSEC

Rezolute, Inc.

Nasdaq:RZLT

Pharmaceutical Preparations·REDWOOD CITY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$70.4M

FY 2025

Net Income

-$68.5M

FY 2025

EPS (Diluted)

-$1.33

FY 2025

Stock Price

$3.25

+4.5%

2026-03-09

52W Range

$1.07 – $11.46

P/E Ratio

-2.4x

Market Cap

$311.0M

Cash

$70.4M

FY 2025

Total Debt

$14.0M

FY 2022

Net Cash

$56.4M

FY 2022

Enterprise Value

$254.6M

Debt / EBITDA

0.8x

FY 2025

EV / EBITDA

-3.6x

Employees

—